Htg Molecular Diagnostics

(NASDAQ) HTGM

Current PriceN/A

Market CapN/A

Since IPO (2015)-100%

5 Year-100%

1 Year-99%

1 Month-99%

Htg Molecular Diagnostics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$6.21M

Net Income (TTM)

$20.15M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

HTGM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Htg Molecular Diagnostics

Industry

Health Care Technology

Sector

Health Care

Employees

CEO

John L. Lubniewski

Website

www.htgmolecular.com

Headquarters

Tucson, AZ 85706, US

HTGM Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-3%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$20.83M

EBITDA

$20.14M

Operating Cash Flow

$18.41M

Capital Expenditure

$23.04K

Free Cash Flow

$18.43M

Cash & ST Invst.

$12.21M

Total Debt

$4.83M

Htg Molecular Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

$1.03M

-12.8%

Gross Profit

$117.10K

-135.5%

Gross Margin

-11.34%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$5.05M

+22.2%

EBITDA

$4.83M

+20.4%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Net Cash

$2.58M

-78.6%

Accounts Receivable

$1.13M

+51.1%

Inventory

$654.92K

-67.6%

Long Term Debt

$423.24K

-89.5%

Short Term Debt

$3.56M

-34.4%

Return on Assets

-1.21%

N/A

Return on Invested Capital

-2.19%

N/A

Free Cash Flow

$4.37M

+26.5%

Operating Cash Flow

$4.36M

+26.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NMTRQ9 Meters Biopharma, Inc.

NMTRQ9 Meters Biopharma, Inc.$0.00+0.00%

NVIVInVivo Therapeutics Holdings Corporation

NVIVInVivo Therapeutics Holdings Corporation$0.32-34.28%

NEPTFNeptune Wellness Solutions Inc.

NEPTFNeptune Wellness Solutions Inc.$0.00+0.00%

CWBRCohBar, Inc.

CWBRCohBar, Inc.$0.41+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About HTGM

What is the current price of Htg Molecular Diagnostics?

Htg Molecular Diagnostics is trading at N/A per share.

What is the 52-week range for Htg Molecular Diagnostics?

Over the past 52 weeks, Htg Molecular Diagnostics has traded between N/A and N/A.

How much debt does Htg Molecular Diagnostics have?

As of the most recent reporting period, Htg Molecular Diagnostics reported total debt of $8.80M.

How much cash does Htg Molecular Diagnostics have on hand?

Htg Molecular Diagnostics reported $12.21M in cash and cash equivalents in its most recent financial results.

What is Htg Molecular Diagnostics’s dividend yield?

Htg Molecular Diagnostics does not currently have a dividend yield.

Htg Molecular Diagnostics

Htg Molecular Diagnostics Financials at a Glance

HTGM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Htg Molecular Diagnostics

HTGM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Htg Molecular Diagnostics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HTGM

What is the current price of Htg Molecular Diagnostics?

What is the 52-week range for Htg Molecular Diagnostics?

How much debt does Htg Molecular Diagnostics have?

How much cash does Htg Molecular Diagnostics have on hand?

What is Htg Molecular Diagnostics’s dividend yield?

Premium Investing Services